Similarly, autophagy blockade by beta-2 adrenergic receptor (ADRB2) in an in vivo HCC model promoted DEN-induced hepatocarcinogenesis and sorafenib resistance acquisition by HIF-1α stabilization [60]. This evidence concerns the gene HIF1A and hepatocellular carcinoma.